(Q36903801)

17 August 2017

1 reference

title

Novel approaches to retinal drug delivery (English)

1 reference

17 August 2017

1 reference

Kumar G Janoria

1

1 reference

17 August 2017

Sriram Gunda

series ordinal

2

1 reference

17 August 2017

Sai H S Boddu

series ordinal

3

1 reference

17 August 2017

Ashim K Mitra

series ordinal

4

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 July 2007

1 reference

Expert Opinion on Drug Delivery

17 August 2017

published in

1 reference

17 August 2017

volume

4

1 reference

17 August 2017

issue

4

1 reference

17 August 2017

page(s)

371-388

1 reference

Advances in the management of AIDS-related cytomegalovirus retinitis

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Site-restricted persistent cytomegalovirus infection after selective long-term depletion of CD4+ T lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Pathophysiology of age-related macular degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Risk factors for diffuse and focal macular edema

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Intravitreal triamcinolone acetonide in eyes with cystoid macular edema associated with central retinal vein occlusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Intravitreal triamcinolone treatment for macular edema associated with central retinal vein occlusion and hemiretinal vein occlusion.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Risk factors for proliferative vitreoretinopathy after primary vitrectomy: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Recurrent retinal detachment more than 1 year after reattachment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

How to predict proliferative vitreoretinopathy: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Anatomical and functional outcomes after heavy silicone oil tamponade in vitreoretinal surgery for complicated retinal detachment: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Adjuvant 5-fluorouracil and heparin prevents proliferative vitreoretinopathy : Results from a randomized, double-blind, controlled clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Proliferative vitreoretinopathy-developments in adjunctive treatment and retinal pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Endogenous posterior uveitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Immunosuppressive drugs in immune and inflammatory ocular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Low-dose methotrexate therapy for ocular inflammatory disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

The diagnosis of cytomegalovirus retinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Treatment of cytomegalovirus retinitis with a sustained-release ganciclovir implant. The Ganciclovir Implant Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

The blood-ocular barriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

The blood-retinal barriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Functional characterization and comparison of the outer blood-retina barrier and the blood-brain barrier

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Expression of multidrug resistance-associated protein (MRP) in human retinal pigment epithelial cells and its interaction with BAPSG, a novel aldose reductase inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Characterization of a rat retinal endothelial cell culture and the expression of P-glycoprotein in brain and retinal endothelium in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Topical and systemic drug delivery to the posterior segments

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Ophthalmic drug delivery systems--recent advances

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Ocular preparations: the formulation approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS. A randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Characterization of a novel intraocular drug-delivery system using crystalline lipid antiviral prodrugs of ganciclovir and cyclic cidofovir.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Kinetics of macromolecules injected into the subretinal space

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Review: practical issues in intravitreal drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Aminoglycoside toxicity--a survey of retinal specialists. Implications for ocular use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

A controlled trial of valganciclovir as induction therapy for cytomegalovirus retinitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

New developments in sustained release drug delivery for the treatment of intraocular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Treatment of thyroid associated ophthalmopathy with periocular injections of triamcinolone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

An audit of peribulbar blockade using 15 mm, 25 mm and 37.5 mm needles, and sub-Tenon's injection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Peribulbar versus retrobulbar anesthesia for ophthalmic surgery: an anatomical comparison of extraconal and intraconal injections.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Intraocular pressure and pulsatile ocular blood flow after retrobulbar and peribulbar anaesthesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Efficacy and complication rate of 16,224 consecutive peribulbar blocks. A prospective multicenter study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Rapid onset of ptosis indicates accurate intraconal placement during retrobulbar anaesthetic injection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Sub-Tenon's anaesthesia: an efficient and safe technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Sub-Tenon's administration of local anaesthetic: a review of the technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

A poly(ortho ester) designed for combined ocular delivery of dexamethasone sodium phosphate and 5-fluorouracil: subconjunctival tolerance and in vitro release

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Transscleral drug delivery for posterior segment disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Drug delivery systems: past, present, and future.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Treatment of cytomegalovirus retinitis with intravitreal injection of liposome encapsulated ganciclovir in a patient with AIDS

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Liposomally-entrapped ganciclovir for the treatment of cytomegalovirus retinitis in AIDS patients. Eperimental toxicity and pharmacokinetics, and clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Biomaterials used in the posterior segment of the eye.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Intravitreal administration of antisense oligonucleotides: potential of liposomal delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Ocular delivery using poly(ortho esters).

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Biodegradable polymers for ocular drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Biodegradation and tissue reaction to intravitreous biodegradable poly(D,L-lactic-co-glycolic)acid microspheres

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Clearance of microsphere-entrapped 5-fluorouracil and cytosine arabinoside from the vitreous of primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Therapeutic and toxicological evaluations of cyclosporine a microspheres as a treatment vehicle for uveitis in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Development of a novel formulation containing poly(d,l-lactide-co-glycolide) microspheres dispersed in PLGA-PEG-PLGA gel for sustained delivery of ganciclovir

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Controlled delivery of ganciclovir to the retina with drug-loaded Poly(d,L-lactide-co-glycolide) (PLGA) microspheres dispersed in PLGA-PEG-PLGA Gel: a novel intravitreal delivery system for the treatment of cytomegalovirus retinitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Ocular disposition and tolerance of ganciclovir-loaded albumin nanoparticles after intravitreal injection in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Intraocular injection of tamoxifen-loaded nanoparticles: a new treatment of experimental autoimmune uveoretinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Ocular drug delivery targeting the retina and retinal pigment epithelium using polylactide nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Effect of particle size of polymeric nanospheres on intravitreal kinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Sustained-release ganciclovir therapy for treatment of cytomegalovirus retinitis. Use of an intravitreal device

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Biodegradable polymeric device for sustained intravitreal release of ganciclovir in rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Visual and anatomic outcomes associated with posterior segment complications after ganciclovir implant procedures in patients with AIDS and cytomegalovirus retinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Intravitreal sustained-release cyclosporine in the treatment of experimental uveitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Long-term follow-up results of a pilot trial of a fluocinolone acetonide implant to treat posterior uveitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Intraocular tissue distribution of betamethasone after intrascleral administration using a non-biodegradable sustained drug delivery device

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Long-term sustained release of ganciclovir from biodegradable scleral implant for the treatment of cytomegalovirus retinitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Biodegradable scleral implant for intravitreal controlled release of fluconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Scleral plug of biodegradable polymers for controlled drug release in the vitreous

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Implantable biodegradable polymeric device in the treatment of experimental proliferative vitreoretinopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Prevention of experimental proliferative vitreoretinopathy with a biodegradable intravitreal implant for the sustained release of fluorouracil

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Scleral plug of biodegradable polymers containing tacrolimus (FK506) for experimental uveitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Intravitreous delivery of dexamethasone sodium m-sulfobenzoate from poly(DL-lactic acid) implants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Biodegradable intrascleral implant for sustained intraocular delivery of betamethasone phosphate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Effect of mono- and di-acylation on the ocular disposition of ganciclovir: physicochemical properties, ocular bioreversion, and antiviral activity of short chain ester prodrugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Functional and molecular analysis of D-serine transport in retinal Müller cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Distribution of monocarboxylate transporters MCT1 and MCT2 in rat retina

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Biotin uptake and cellular translocation in human derived retinoblastoma cell line (Y-79): a role of hSMVT system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Identification and functional characterization of riboflavin transporter in human-derived retinoblastoma cell line (Y-79): mechanisms of cellular uptake and translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Localization and possible function of the glutamate transporter, EAAC1, in the rat retina

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

21 January 2018

Membrane transporters

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Molecular interactions between dipeptides, drugs and the human intestinal H+ -oligopeptide cotransporter hPEPT1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Mechanisms of 5-aminolevulinic acid uptake at the choroid plexus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Interactions of the dipeptide ester prodrugs of acyclovir with the intestinal oligopeptide transporter: competitive inhibition of glycylsarcosine transport in human intestinal cell line-Caco-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Dipeptide monoester ganciclovir prodrugs for treating HSV-1-induced corneal epithelial and stromal keratitis: in vitro and in vivo evaluations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Mechanism of corneal permeation of L-valyl ester of acyclovir: targeting the oligopeptide transporter on the rabbit cornea

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Mechanism of a model dipeptide transport across blood-ocular barriers following systemic administration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Amino acid prodrugs of acyclovir as possible antiviral agents against ocular HSV-1 infections: interactions with the neutral and cationic amino acid transporter on the corneal epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Identification of a Na+-dependent cationic and neutral amino acid transporter, B(0,+), in human and rabbit cornea

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

The expression of lactate transporters (MCT1 and MCT4) in heart and muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

The proton-linked monocarboxylate transporter (MCT) family: structure, function and regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Human monocarboxylate transporter 2 (MCT2) is a high affinity pyruvate transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

MCT1-mediated transport of L-lactic acid at the inner blood-retinal barrier: a possible route for delivery of monocarboxylic acid drugs to the retina

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Expression and differential polarization of the reduced-folate transporter-1 and the folate receptor alpha in mammalian retinal pigment epithelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Evaluation of an ex vivo model implication for carrier-mediated retinal drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Effect of P-glycoprotein on the ocular disposition of a model substrate, quinidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Topical iontophoretic drug delivery in vivo: historical development, devices and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

An electrically modulated drug delivery device. III. Factors affecting drug stability during electrophoresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Improvement on conventional constant current DC iontophoresis: a study using constant conductance AC iontophoresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Iontophoretic drug delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Characterization of the Pore Transport Properties and Tissue Alteration of Excised Human Skin during Iontophoresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Delivery of gentamicin to the rabbit eye by drug-loaded hydrogel iontophoresis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

In vivo transscleral iontophoresis of amikacin to rabbit eyes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Iontophoretic application of tobramycin to uninfected and Pseudomonas aeruginosa-infected rabbit corneas

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Transdermal iontophoresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Recent progress in ocular drug delivery for posterior segment disease: emphasis on transscleral iontophoresis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Ocular drug delivery using 20-kHz ultrasound

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

Ultrasound-enhanced transcorneal drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.4.4.371

21 January 2018

Identifiers

DOI

10.1517/17425247.4.4.371

1 reference

17 August 2017

1 reference